Rchr
J-GLOBAL ID:201801021296762038   Update date: Feb. 13, 2024

Takafumi Narisawa

ナリサワ タカフミ | Takafumi Narisawa
Research field  (3): Urology ,  Pharmacology ,  Pathobiochemistry
Research theme for competitive and other funds  (2):
  • 2021 - 2026 淡明型腎細胞癌における5番染色体長腕伸長の生物学的意義について
  • 2022 - 2025 Metabolome analysis for identification of urothelial carcinoma metabotypes and exploration of diagnostic and therapeutic targets
Papers (46):
  • Yuji Takeda, Tomoyuki Kato, Saima Sabrina, Sei Naito, Hiromi Ito, Naoto Emi, Yuya Kuboki, Yuki Takai, Hiroki Fukuhara, Masaki Ushijima, et al. Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette-Guérin. Biomedicines. 2023. 11. 11
  • Hayato Nishida, Satoshi Takai, Hiromi Ito, Hiroki Fukuhara, Takaaki Nawano, Takafumi Narisawa, Hidenori Kanno, Mayu Yagi, Atsushi Yamagishi, Toshihiko Sakurai, et al. Anti-human leukocyte antigen and anti-ABO antibodies after SARS-CoV-2 mRNA vaccination in kidney transplant recipients. Clinical transplantation. 2023. e14952
  • Takafumi Narisawa, Sei Naito, Hiromi Ito, Osamu Ichiyanagi, Toshihiko Sakurai, Tomoyuki Kato, Norihiko Tsuchiya. Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma. BMC cancer. 2023. 23. 1. 170-170
  • Satoshi Takai, Hayato Nishida, Hiromi Ito, Hiroki Fukuhara, Takaaki Nawano, Takafumi Narisawa, Hidenori Kanno, Mayu Yagi, Atsushi Yamagishi, Toshihiko Sakurai, et al. Immunogenicity and safety of two doses of SARS-CoV-2 mRNA vaccine in kidney transplant recipients with low-dose rituximab. International journal of urology : official journal of the Japanese Urological Association. 2022. 29. 11. 1279-1286
  • Hidenori Kanno, Sei Naito, Yutaro Obara, Hiromi Ito, Osamu Ichiyanagi, Takafumi Narisawa, Tomoyuki Kato, Akira Nagaoka, Norihiko Tsuchiya. Effect of Extracellular Signal-Regulated Protein Kinase 5 Inhibition in Clear Cell Renal Cell Carcinoma. International journal of molecular sciences. 2022. 23. 15
more...
MISC (58):
Work history (1):
  • 2017/04 - 現在 Yamagata University Faculty of Medicine
Association Membership(s) (5):
THE JAPAN SOCIETY OF UROLOGIC ONCOLOGY ,  JAPANESE SOCIETY OF ENDOUROLOGY ,  JAPAN SOCIETY OF CLINICAL ONCOLOGY ,  THE JAPANESE CANCER ASSOCIATION ,  THE JAPANESE UROLOGICAL ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page